Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.14B | 3.14B | 3.10B | 2.94B | 2.77B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.14B | 3.14B | 3.10B | 2.94B | 2.77B |
| Cost of Revenue | 963.05M | 975.71M | 977.07M | 938.35M | 899.84M |
| Gross Profit | 2.18B | 2.17B | 2.12B | 2.00B | 1.87B |
| SG&A Expenses | 1.17B | 1.17B | 1.19B | 1.14B | 1.09B |
| Depreciation & Amortization | 118.02M | 118.29M | 118.92M | 118.19M | 118.75M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.40B | 2.42B | 2.44B | 2.34B | 2.25B |
| Operating Income | 740.90M | 729.24M | 660.22M | 596.51M | 520.17M |
| Income Before Tax | 699.39M | 660.12M | 658.47M | 605.07M | 460.50M |
| Income Tax Expenses | 141.76M | 124.69M | 71.77M | 67.20M | 36.72M |
| Earnings from Continuing Operations | 557.64 | 535.43 | 586.71 | 537.87 | 423.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 557.64M | 535.43M | 586.71M | 537.87M | 423.78M |
| EBIT | 740.90M | 729.24M | 660.22M | 596.51M | 520.17M |
| EBITDA | 1.02B | 1.01B | 940.63M | 872.69M | 794.58M |
| EPS Basic | 4.14 | 3.97 | 4.35 | 3.98 | 3.13 |
| Normalized Basic EPS | 3.51 | 3.44 | 3.09 | 2.80 | 2.29 |
| EPS Diluted | 4.06 | 3.90 | 4.29 | 3.93 | 3.10 |
| Normalized Diluted EPS | 3.45 | 3.39 | 3.05 | 2.76 | 2.26 |
| Average Basic Shares Outstanding | 538.98M | 539.33M | 539.48M | 540.88M | 543.19M |
| Average Diluted Shares Outstanding | 548.17M | 547.54M | 546.66M | 548.24M | 551.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |